ADRIB(Doxorubicin)
Therapeutic class: cytotoxic anthracycline antibiotic
- primary breast cancer
- Acute lymphoblastic leukemia
- Acute myeloblastic leukemia
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
- Metastatic breast cancer
- Metastatic Wilms’ tumor
- Metastatic neuroblastoma
- Metastatic soft tissue sarcoma
- Metastatic bone sarcomas
- Metastatic ovarian carcinoma
- Metastatic transitional cell bladder carcinoma
- Metastatic thyroid carcinoma
- Metastatic gastric carcinoma
- Metastatic bronchogenic carcinoma
-10 mg / 5ml & 50 mg/25ml injection
- 2°C to 8°C , Shelf Life: 2 Years
- As directed by physician
